デフォルト表紙
市場調査レポート
商品コード
1786829

POC脂質検査の世界市場、規模、シェア、動向、産業分析レポート:製品別、用途別、適応疾患別、最終用途別、地域別 - 市場予測、2025年~2034年

Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region - Market Forecast, 2025-2034


出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
POC脂質検査の世界市場、規模、シェア、動向、産業分析レポート:製品別、用途別、適応疾患別、最終用途別、地域別 - 市場予測、2025年~2034年
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、POC脂質検査市場規模は2034年までに13億9,297万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

POC脂質検査は、総コレステロール、HDL、LDL、トリグリセリドなどの脂質値を患者の診療現場で直接測定するために使用される診断ツールです。少量の血液サンプルから、多くの場合、数分以内に、中央検査室を必要としない迅速な結果が得られます。

政府や保健機関は、心臓病の減少を目的とした国民保健プログラムの一環として、日常的なコレステロール・スクリーニングを推進しています。多くの公衆衛生キャンペーンでは、特に肥満、糖尿病、心血管疾患の家族歴などの危険因子を持つ人々に対して、早期発見と定期的な脂質検査を強調しています。国によっては、地域の診療所や薬局でのPOC検査に資金やインセンティブを提供しているところもあります。このような努力は、集団全体におけるPOC脂質検査の正常化と利用の増加に役立っています。強力な政策支援と資金提供は、市場の成長とアクセシビリティをさらに加速します。

疾病を早期に発見し、あるいは完全に回避することを目標とする、反応的医療から予防的医療へのシフトが進んでいます。脂質検査は、症状が現れる前に心臓病や関連疾患のリスクを特定するための重要なツールです。POC検査機器は、このプロセスをより迅速かつ容易にし、特に高リスク群において、より頻繁な検査を促します。これらの検査は、早期の介入と生活習慣の改善を可能にすることによって、より良い健康結果をサポートします。患者と医療提供者の間で予防医療に対する意識が高まるにつれて、簡便な脂質検査オプションに対する需要が大幅に増加しており、POC脂質検査市場の成長を牽引しています。

POC脂質検査市場レポートハイライト

2024年、消耗品セグメントが最大シェアを占め、これらのアイテムはすべての検査に不可欠であり、定期的に交換する必要があるため、一貫した需要を促進しています。

肥満率の上昇により高トリグリセリド血症がますます一般的になっているため、高トリグリセリド血症セグメントが予測期間中に大きな成長が見込まれます。

北米市場は、心血管疾患の有病率の上昇、高齢化、整備された医療インフラに牽引され、2024年に最大のシェアを占めました。

アジア太平洋地域市場は、心血管疾患患者の増加、健康意識の高まり、医療サービスへのアクセス拡大を背景に、予測期間中に大幅な成長が見込まれます。

世界の主要な市場プレーヤーには、Abbott Laboratories、Callegari Srl、F. Hoffmann-La Roche Ltd.、Menarini Group、MiCoBio、Nova Biomedical、SD Biosensor, Inc.などが含まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のPOC脂質検査市場の洞察

  • 市場スナップショット
  • POC脂質検査市場力学
    • 促進要因と機会
      • 高齢化社会
      • 心血管疾患の有病率の上昇
    • 抑制要因と課題
      • 初期投資額が高め
  • PESTEL分析
  • POC脂質検査市場の動向
  • バリューチェーン分析

第5章 世界のPOC脂質検査市場:製品別

  • 主な調査結果
  • イントロダクション
  • 機器
  • 消耗品

第6章 世界のPOC脂質検査市場:用途別

  • 主な調査結果
  • イントロダクション
  • 高脂血症
  • 高トリグリセリド血症
  • タンジール病
  • 高リポタンパク血症
  • 家族性高コレステロール血症
  • その他

第7章 世界のPOC脂質検査市場:適応疾患別

  • 主な調査結果
  • イントロダクション
  • 脂質・リポタンパク質疾患
  • 動脈硬化症
  • 肝臓・腎臓疾患
  • 糖尿病
  • その他

第8章 世界のPOC脂質検査市場:最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • 研究・診断研究所
  • その他

第9章 世界のPOC脂質検査市場:地域別

  • 主な調査結果
  • イントロダクション
    • POC脂質検査市場分析:地域別、2020年~2034年
  • 北米
    • 北米:製品別、2020~2034年
    • 北米:用途別、2020~2034年
    • 北米:疾患別、2020~2034年
    • 北米:最終用途別、2020~2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州:製品別、2020~2034年
    • 欧州:用途別、2020~2034年
    • 欧州:疾患別、2020~2034年
    • 欧州:最終用途別、2020~2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域:製品別、2020~2034年
    • アジア太平洋地域:用途別、2020~2034年
    • アジア太平洋地域:疾患別、2020年~2034年
    • アジア太平洋地域:最終用途別、2020~2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ:製品別、2020~2034年
    • 中東・アフリカ:用途別、2020~2034年
    • 中東・アフリカ:疾患別、2020年~2034年
    • 中東・アフリカ:最終用途別、2020~2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ:製品別、2020~2034年
    • ラテンアメリカ:用途別、2020~2034年
    • ラテンアメリカ:疾患別、2020年~2034年
    • ラテンアメリカ:最終用途別、2020~2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第10章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Abbott Laboratories
  • Callegari Srl
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • MiCoBio
  • Nova Biomedical
  • SD Biosensor, Inc.
  • Sinocare Inc.
  • VivaChek Biotech(Hangzhou)Co., Ltd.
図表

List of Tables:

  • Table 1 Global Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 2 Global Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 3 Global Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 4 Global Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 5 North America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 6 North America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 7 North America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 8 North America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 9 US: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 10 US: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 11 US: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 12 US: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 13 Canada: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 14 Canada: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 15 Canada: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 16 Canada: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 17 Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 18 Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 19 Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 20 Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 21 UK: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 22 UK: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 23 UK: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 24 UK: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 25 France: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 26 France: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 27 France: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 28 France: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 29 Germany: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 30 Germany: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 31 Germany: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 32 Germany: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 33 Italy: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 34 Italy: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 35 Italy: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 36 Italy: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 37 Spain: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 38 Spain: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 39 Spain: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 40 Spain: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 41 Netherlands: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 42 Netherlands: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 43 Netherlands: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 44 Netherlands: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 45 Russia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 46 Russia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 47 Russia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 48 Russia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 49 Rest of Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 50 Rest of Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 51 Rest of Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 52 Rest of Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 53 Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 54 Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 55 Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 56 Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 57 China: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 58 China: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 59 China: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 60 China: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 61 India: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 62 India: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 63 India: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 64 India: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 65 Malaysia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 66 Malaysia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 67 Malaysia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 68 Malaysia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 69 Japan: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 70 Japan: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 71 Japan: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 72 Japan: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 73 Indonesia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 74 Indonesia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 75 Indonesia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 76 Indonesia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 77 South Korea: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 78 South Korea: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 79 South Korea: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 80 South Korea: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 81 Australia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 82 Australia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 83 Australia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 84 Australia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 85 Rest of Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 86 Rest of Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 87 Rest of Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 88 Rest of Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 89 Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 90 Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 91 Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 92 Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 93 Saudi Arabia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 94 Saudi Arabia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 95 Saudi Arabia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 96 Saudi Arabia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 97 UAE: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 98 UAE: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 99 UAE: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 100 UAE: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 101 Israel: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 102 Israel: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 103 Israel: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 104 Israel: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 105 South Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 106 South Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 107 South Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 108 South Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 109 Rest of Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 110 Rest of Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 111 Rest of Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 112 Rest of Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 113 Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 114 Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 115 Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 116 Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 117 Mexico: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 118 Mexico: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 119 Mexico: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 120 Mexico: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 121 Brazil: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 122 Brazil: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 123 Brazil: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 124 Brazil: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 125 Argentina: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 126 Argentina: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 127 Argentina: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 128 Argentina: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • Table 129 Rest of Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • Table 130 Rest of Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • Table 131 Rest of Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
  • Table 132 Rest of Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)

List of Figures:

  • Figure 1. Global Point of Care Lipid Test Market, 2020-2034 (USD million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Point of Care Lipid Test Market, by Product, 2024 & 2034 (USD million)
  • Figure 8. Market by Application
  • Figure 9. Global Point of Care Lipid Test Market, by Application, 2024 & 2034 (USD million)
  • Figure 10. Market by Disease Indication
  • Figure 11. Global Point of Care Lipid Test Market, by Disease Indication, 2024 & 2034 (USD million)
  • Figure 12. Market by End Use
  • Figure 13. Global Point of Care Lipid Test Market, by End Use, 2024 & 2034 (USD million)
  • Figure 14. Global Point of Care Lipid Test Market Assessment, By Geography, 2020-2034 (USD million)
  • Figure 15. Strategic Analysis - Global Point of Care Lipid Test Market
目次
Product Code: PM6107

The point of care (POC) lipid test market size is expected to reach USD 1,392.97 million by 2034, according to a new study by Polaris Market Research. The report "Point of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Consumables), By Application, By Disease Indication, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A point of care (POC) lipid test is a diagnostic tool used to measure lipid levels such as total cholesterol, HDL, LDL, and triglycerides, directly at the site of patient care. It provides rapid results from a small blood sample, often within minutes, without needing a central laboratory.

Governments and health organizations are promoting routine cholesterol screening as part of national health programs aimed at reducing heart disease. Many public health campaigns emphasize early detection and regular lipid testing, especially for people with risk factors such as obesity, diabetes, or a family history of cardiovascular conditions. Some countries further provide funding or incentives for point of care testing in community clinics and pharmacies. These efforts are helping to normalize and increase the use of POC lipid tests across populations. Strong policy support and funding further accelerate the growth and accessibility of the market.

There is a growing shift from reactive to preventive healthcare, where the goal is to catch diseases early or avoid them altogether. Lipid testing is a key tool in identifying risks for heart disease and related conditions before symptoms appear. Point of care testing devices make this process faster and easier, encouraging more frequent testing, especially in high-risk groups. These tests support better health outcomes by enabling early intervention and lifestyle changes. The demand for convenient lipid testing options is increasing significantly as awareness of preventive care rises among both patients and providers, thereby driving the POC lipid test market growth.

Point of Care Lipid Test Market Report Highlights

In 2024, the consumables segment dominated with the largest share as these items are essential for every test and need to be replaced regularly, fueling consistent demand.

The hypertriglyceridemia segment is expected to experience significant growth during the forecast period as hypertriglyceridemia is becoming increasingly common due to rising obesity rates.

The market in North America dominated with the largest share in 2024, driven by rising cardiovascular disease prevalence, an aging population, and well-established healthcare infrastructure.

The Asia Pacific market is projected to witness substantial growth during the forecast period, driven by increasing cardiovascular disease cases, growing health awareness, and expanding access to healthcare services.

A few global key market players are Abbott Laboratories; Callegari Srl; F. Hoffmann-La Roche Ltd.; Menarini Group; MiCoBio; Nova Biomedical; SD Biosensor, Inc.; Sinocare Inc.; and VivaChek Biotech (Hangzhou) Co., Ltd.

Polaris Market Research has segmented the point of care lipid test market report on the basis of product, application, disease indication, end use, and region:

By Product (Revenue - USD Million, 2020-2034)

Instruments

Consumables

By Application (Revenue - USD Million, 2020-2034)

Hyperlipidemia

Hypertriglyceridemia

Tangier Disease

Hyperlipoproteinemia

Familial Hypercholesterolemia

Others

By Disease Indication (Revenue - USD Million, 2020-2034)

Lipid and Lipoprotein Disorders

Atherosclerosis

Liver and Renal Diseases

Diabetes Mellitus

Others

By End Use (Revenue - USD Million, 2020-2034)

Hospitals

Clinics

Research and Diagnostic Laboratories

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Point of Care Lipid Test Market Insights

  • 4.1. Point of Care Lipid Test Market - Market Snapshot
  • 4.2. Point of Care Lipid Test Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Ageing Population
      • 4.2.1.2. Rising Prevalence of Cardiovascular Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Point of Care Lipid Test Market Trends
  • 4.6. Value Chain Analysis

5. Global Point of Care Lipid Test Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
  • 5.3. Instruments
    • 5.3.1. Global Point of Care Lipid Test Market, by Instruments, by Region, 2020-2034 (USD million)
  • 5.4. Consumables
    • 5.4.1. Global Point of Care Lipid Test Market, by Consumables, by Region, 2020-2034 (USD million)

6. Global Point of Care Lipid Test Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
  • 6.3. Hyperlipidemia
    • 6.3.1. Global Point of Care Lipid Test Market, by Hyperlipidemia, by Region, 2020-2034 (USD million)
  • 6.4. Hypertriglyceridemia
    • 6.4.1. Global Point of Care Lipid Test Market, by Hypertriglyceridemia, by Region, 2020-2034 (USD million)
  • 6.5. Tangier Disease
    • 6.5.1. Global Point of Care Lipid Test Market, by Tangier Disease, by Region, 2020-2034 (USD million)
  • 6.6. Hyperlipoproteinemia
    • 6.6.1. Global Point of Care Lipid Test Market, by Hyperlipoproteinemia, by Region, 2020-2034 (USD million)
  • 6.7. Familial Hypercholesterolemia
    • 6.7.1. Global Point of Care Lipid Test Market, by Familial Hypercholesterolemia, by Region, 2020-2034 (USD million)
  • 6.8. Others
    • 6.8.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)

7. Global Point of Care Lipid Test Market, by Disease Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Point of Care Lipid Test Market, by Medical Biotechnology, 2020-2034 (USD million)
  • 7.3. Lipid and Lipoprotein Disorders
    • 7.3.1. Global Point of Care Lipid Test Market, by Lipid and Lipoprotein Disorders, by Region, 2020-2034 (USD million)
  • 7.4. Atherosclerosis
    • 7.4.1. Global Point of Care Lipid Test Market, by Atherosclerosis, by Region, 2020-2034 (USD million)
  • 7.5. Liver and Renal Diseases
    • 7.5.1. Global Point of Care Lipid Test Market, by Liver and Renal Diseases, by Region, 2020-2034 (USD million)
  • 7.6. Diabetes Mellitus
    • 7.6.1. Global Point of Care Lipid Test Market, by Diabetes Mellitus, by Region, 2020-2034 (USD million)
  • 7.7. Others
    • 7.7.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)

8. Global Point of Care Lipid Test Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 8.3. Hospitals
    • 8.3.1. Global Point of Care Lipid Test Market, by Hospitals, by Region, 2020-2034 (USD million)
  • 8.4. Clinics
    • 8.4.1. Global Point of Care Lipid Test Market, by Clinics, by Region, 2020-2034 (USD million)
  • 8.5. Research and Diagnostic Laboratories
    • 8.5.1. Global Point of Care Lipid Test Market, by Research and Diagnostic Laboratories, by Region, 2020-2034 (USD million)
  • 8.6. Others
    • 8.6.1. Global Point of Care Lipid Test Market, by Others, by Region, 2020-2034 (USD million)

9. Global Point of Care Lipid Test Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Point of Care Lipid Test Market Assessment, By Geography, 2020-2034 (USD million)
  • 9.3. Point of Care Lipid Test Market - North America
    • 9.3.1. North America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.3.2. North America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.3.3. North America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.3.4. North America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.3.5. Point of Care Lipid Test Market - US
      • 9.3.5.1. US: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.3.5.2. US: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.3.5.3. US: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.3.5.4. US: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.3.6. Point of Care Lipid Test Market - Canada
      • 9.3.6.1. Canada: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.3.6.2. Canada: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.3.6.3. Canada: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.3.6.4. Canada: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.4. Point of Care Lipid Test Market - Europe
    • 9.4.1. Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.4.2. Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.4.3. Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.4.4. Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.5. Point of Care Lipid Test Market - UK
      • 9.4.5.1. UK: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.5.2. UK: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.5.3. UK: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.5.4. UK: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.6. Point of Care Lipid Test Market - France
      • 9.4.6.1. France: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.6.2. France: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.6.3. France: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.6.4. France: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.7. Point of Care Lipid Test Market - Germany
      • 9.4.7.1. Germany: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.7.2. Germany: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.7.3. Germany: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.7.4. Germany: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.8. Point of Care Lipid Test Market - Italy
      • 9.4.8.1. Italy: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.8.2. Italy: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.8.3. Italy: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.8.4. Italy: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.9. Point of Care Lipid Test Market - Spain
      • 9.4.9.1. Spain: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.9.2. Spain: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.9.3. Spain: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.9.4. Spain: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.10. Point of Care Lipid Test Market - Netherlands
      • 9.4.10.1. Netherlands: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.10.2. Netherlands: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.10.3. Netherlands: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.10.4. Netherlands: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.11. Point of Care Lipid Test Market - Russia
      • 9.4.11.1. Russia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.11.2. Russia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.11.3. Russia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.11.4. Russia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.4.12. Point of Care Lipid Test Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.4.12.2. Rest of Europe: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.4.12.3. Rest of Europe: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.4.12.4. Rest of Europe: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.5. Point of Care Lipid Test Market - Asia Pacific
    • 9.5.1. Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.5.2. Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.5.3. Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.5.4. Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.5. Point of Care Lipid Test Market - China
      • 9.5.5.1. China: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.5.2. China: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.5.3. China: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.5.4. China: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.6. Point of Care Lipid Test Market - India
      • 9.5.6.1. India: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.6.2. India: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.6.3. India: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.6.4. India: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.7. Point of Care Lipid Test Market - Malaysia
      • 9.5.7.1. Malaysia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.7.2. Malaysia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.7.3. Malaysia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.7.4. Malaysia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.8. Point of Care Lipid Test Market - Japan
      • 9.5.8.1. Japan: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.8.2. Japan: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.8.3. Japan: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.8.4. Japan: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.9. Point of Care Lipid Test Market - Indonesia
      • 9.5.9.1. Indonesia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.9.2. Indonesia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.9.3. Indonesia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.9.4. Indonesia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.10. Point of Care Lipid Test Market - South Korea
      • 9.5.10.1. South Korea: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.10.2. South Korea: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.10.3. South Korea: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.10.4. South Korea: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.11. Point of Care Lipid Test Market - Australia
      • 9.5.11.1. Australia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.11.2. Australia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.11.3. Australia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.11.4. Australia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.5.12. Point of Care Lipid Test Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.5.12.2. Rest of Asia Pacific: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.5.12.3. Rest of Asia Pacific: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.5.12.4. Rest of Asia Pacific: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.6. Point of Care Lipid Test Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.6.2. Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.6.3. Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.6.4. Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.5. Point of Care Lipid Test Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.5.2. Saudi Arabia: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.5.3. Saudi Arabia: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.5.4. Saudi Arabia: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.6. Point of Care Lipid Test Market - UAE
      • 9.6.6.1. UAE: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.6.2. UAE: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.6.3. UAE: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.6.4. UAE: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.7. Point of Care Lipid Test Market - Israel
      • 9.6.7.1. Israel: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.7.2. Israel: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.7.3. Israel: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.7.4. Israel: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.8. Point of Care Lipid Test Market - South Africa
      • 9.6.8.1. South Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.8.2. South Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.8.3. South Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.8.4. South Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.6.9. Point of Care Lipid Test Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.6.9.2. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.6.9.3. Rest of Middle East & Africa: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.6.9.4. Rest of Middle East & Africa: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
  • 9.7. Point of Care Lipid Test Market - Latin America
    • 9.7.1. Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
    • 9.7.2. Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
    • 9.7.3. Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
    • 9.7.4. Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.5. Point of Care Lipid Test Market - Mexico
      • 9.7.5.1. Mexico: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.5.2. Mexico: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.5.3. Mexico: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.5.4. Mexico: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.6. Point of Care Lipid Test Market - Brazil
      • 9.7.6.1. Brazil: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.6.2. Brazil: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.6.3. Brazil: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.6.4. Brazil: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.7. Point of Care Lipid Test Market - Argentina
      • 9.7.7.1. Argentina: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.7.2. Argentina: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.7.3. Argentina: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.7.4. Argentina: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)
    • 9.7.8. Point of Care Lipid Test Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Point of Care Lipid Test Market, by Product, 2020-2034 (USD million)
      • 9.7.8.2. Rest of Latin America: Point of Care Lipid Test Market, by Application, 2020-2034 (USD million)
      • 9.7.8.3. Rest of Latin America: Point of Care Lipid Test Market, by Disease Indication, 2020-2034 (USD million)
      • 9.7.8.4. Rest of Latin America: Point of Care Lipid Test Market, by End Use, 2020-2034 (USD million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Callegari Srl
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. F. Hoffmann-La Roche Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Menarini Group
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. MiCoBio
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Nova Biomedical
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. SD Biosensor, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Sinocare Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. VivaChek Biotech (Hangzhou) Co., Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development